Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 76629-11-3 | MDL No. : | MFCD18915444 |
Formula : | C8H9ClN2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | AGUQXLJLUUWXDE-UHFFFAOYSA-N |
M.W : | 200.62 | Pubchem ID : | 12619167 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.25 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 49.94 |
TPSA : | 62.22 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.98 cm/s |
Log Po/w (iLOGP) : | 1.05 |
Log Po/w (XLOGP3) : | 2.18 |
Log Po/w (WLOGP) : | 1.43 |
Log Po/w (MLOGP) : | 0.8 |
Log Po/w (SILICOS-IT) : | 1.25 |
Consensus Log Po/w : | 1.34 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -2.53 |
Solubility : | 0.586 mg/ml ; 0.00292 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.12 |
Solubility : | 0.152 mg/ml ; 0.000759 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.88 |
Solubility : | 0.264 mg/ml ; 0.00132 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.82 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 29449-86-3 ]
3-((6-Chloropyridin-2-yl)amino)propan-1-ol
Similarity: 0.89
[ 1220028-34-1 ]
4-((6-Chloropyridin-2-yl)amino)butan-2-ol
Similarity: 0.86
[ 1220038-06-1 ]
6-Chloro-N-(3-ethoxypropyl)pyridin-2-amine
Similarity: 0.83
[ 40263-65-8 ]
6-Chloro-N-propylpyridin-2-amine
Similarity: 0.82
[ 3298-29-1 ]
N-Butyl-6-chloropyridin-2-amine
Similarity: 0.81
[ 29449-86-3 ]
3-((6-Chloropyridin-2-yl)amino)propan-1-ol
Similarity: 0.89
[ 1220028-34-1 ]
4-((6-Chloropyridin-2-yl)amino)butan-2-ol
Similarity: 0.86
[ 1220038-06-1 ]
6-Chloro-N-(3-ethoxypropyl)pyridin-2-amine
Similarity: 0.83
[ 40263-65-8 ]
6-Chloro-N-propylpyridin-2-amine
Similarity: 0.82
[ 3298-29-1 ]
N-Butyl-6-chloropyridin-2-amine
Similarity: 0.81
[ 1185293-81-5 ]
3-(4-(Pyridin-2-yl)piperazin-1-yl)propanoic acid hydrochloride
Similarity: 0.74
[ 1172891-02-9 ]
3-(4-(Pyridin-2-yl)piperazin-1-yl)propanoic acid dihydrochloride
Similarity: 0.74
[ 104373-85-5 ]
3-(4-(Pyridin-2-yl)piperazin-1-yl)propanoic acid
Similarity: 0.72
[ 1380300-81-1 ]
1-(Pyridin-2-yl)azetidine-3-carboxylic acid
Similarity: 0.71
[ 339005-94-6 ]
4-((5-Chloropyridin-2-yl)amino)-4-oxobutanoic acid
Similarity: 0.71
[ 29449-86-3 ]
3-((6-Chloropyridin-2-yl)amino)propan-1-ol
Similarity: 0.89
[ 1220028-34-1 ]
4-((6-Chloropyridin-2-yl)amino)butan-2-ol
Similarity: 0.86
[ 1220038-06-1 ]
6-Chloro-N-(3-ethoxypropyl)pyridin-2-amine
Similarity: 0.83
[ 40263-65-8 ]
6-Chloro-N-propylpyridin-2-amine
Similarity: 0.82
[ 3298-29-1 ]
N-Butyl-6-chloropyridin-2-amine
Similarity: 0.81